SciBase Holding AB (5J30) AI Stock Analysis

SciBase Holding AB

(Frankfurt:5J30)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue GrowthTTM revenue growth of about 14.2%, following steady expansion since 2021, indicates improving commercial traction for Nevisense. If maintained, this broader revenue base can help spread fixed costs and provide a foundation for eventual operating leverage over the next several quarters.

Negative Factors

Persistent LossesThe company remains deeply unprofitable, with a TTM net margin near -208% and a cost base still far ahead of scale. Persistent losses can absorb capital, delay self-funded growth, and make the durability of the business model dependent on a substantial improvement in operating efficiency.

SciBase Holding AB (5J30) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 15.91M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.8
Beta (1Y): 15.25
Revenue Growth: 56.54%
EPS Growth: 40.45%
Country: Germany
Employees: 50
Sector: General
Sector Strength: 55
Industry: Medical - Devices

SciBase Holding AB Business Overview & Revenue Model

Company Description

SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key...

SciBase Holding AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

DE:5J30 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:SECT.B	74Outperform	SEK 67.51B	105.81	30.26%	0.38%	13.94%	5.70%
SE:PAX	57Neutral	SEK 1.54B	-303.85	-1.22%	―	34.05%	-144.96%
SE:SEZI	57Neutral	SEK 532.17M	-5.46	-35.44%	―	18.56%	28.11%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
SE:ACARIX	40Underperform	SEK 223.04M	-5.29	-100.09%	―	65.82%	41.28%
SE:SPEC	40Underperform	SEK 20.68M	-0.12	-57.15%	―	―	16.02%

* General Sector Average

Performance Comparison

DE:5J30 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:5J30	SciBase Holding AB	1.02	-2.32	-69.34%
SE:PAX	Paxman AB	66.30	0.10	0.15%
SE:SEZI	Senzime AB	3.38	-2.24	-39.77%
SE:SPEC	SpectraCure AB	0.01	-0.14	-90.73%
SE:SECT.B	Sectra AB Class B	346.00	51.75	17.59%
SE:ACARIX	Acarix AB	0.18	-0.09	-32.96%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

SciBase Holding AB AI Stock Analysis